The comparison of insulin sensitivity in non-diabetic hemodialysis patients treated with and without recombinant human erythropoietin

Hormone and Metabolic Research

Volumn 36, Issue 10, 2004, Pages 716-720

  Tuzcu, A ^a,b   Bahceci, M ^a   Yilmaz, E ^a   Bahceci, S ^a   Tuzcu, S ^a  

^a DICLE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^b DICLE UNIVERSITY   (Turkey)

Author keywords

EPO; Hemodialysis; HOMA ( B); HOMA ( S); Insulin; Uremia

Indexed keywords

INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; RECOMBINANT ERYTHROPOIETIN; TRIACYLGLYCEROL;

ADULT; AGE DISTRIBUTION; AGED; ANALYSIS OF VARIANCE; ANTHROPOMETRY; ARTICLE; CELL FUNCTION; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION COEFFICIENT; FEMALE; GLUCOSE TOLERANCE; HEMODIALYSIS PATIENT; HUMAN; INSULIN BLOOD LEVEL; INSULIN SENSITIVITY; KIDNEY FAILURE; LIPID BLOOD LEVEL; MALE; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; SEX DIFFERENCE; STATISTICAL ANALYSIS; TRIACYLGLYCEROL BLOOD LEVEL; UREMIA;

ADULT; AGED; BLOOD PRESSURE; CALCITRIOL; ERYTHROPOIETIN, RECOMBINANT; FEMALE; HUMANS; INSULIN; INSULIN RESISTANCE; ISLETS OF LANGERHANS; KIDNEY FAILURE, CHRONIC; LIPIDS; MALE; MIDDLE AGED; RENAL DIALYSIS;

EID: 8444233582     PISSN: 00185043     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2004-826021     Document Type: Article

References (20)

1. Shinohara K, Shoji T, Emoto M, Tahara H, Koyama H, Ishimura E, Miki T, Tabata T, Nishizawa Y. Insulin resistance as an independent predictor of cardiovascular mortality inpatients with end-stage renal disease. J Am Soc Nephrol 2002; 13: 1894-1900
2. Hager SR. Insulin resistance of uremia. Am J Kidney Dis 1989; 14: 272-276
3. Spaia S, Pangalos M, Askepidis N, Pazarloglou M, Mavropoulou E, Theodoridis S, Dimitrakopoulos K, Milionis A, Vayonas G. Effect of short-term rHuEPO treatment on insulin resistance in hemodialysis patients. Nephron 2000; 84: 320-325
4. Rasic-Milutinovic Z, Perunicic-Pekovic G, Pljesa S. Clinical significance and pathogenic mechanisms of insulin resistance in chronic renal insufficiency (part II): pathogenic factors of insulin resistance in chronic renal insufficiency. Med Pregl 2000; 53: 159-163
5. Oshida Y, Sato Y, Shiraishi S, Sakamoto N. Studies on glucose intolerance in chronic renal failure: Estimation of insulin sensitivity before and after initiation of hemodialysis. Clin Nephrol 1987; 28: 35-38
6. Matthews DR, Hosker JP, Rudenski AS, Burnett MA, Darling P et al. Homeostasis model assessment: insulin resitance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-419
7. Perez-Martin A, Raynaud E, Hentgen C, Bringer J, Mercier J, Brun JF. Simplified measurement of insulin sensitivity with the minimal model procedure in type 2 diabetic patients without measurement of insulinemia. Horm Metab Res 2002; 34: 102-106
8. Mak RH. 1,25 dihydroxycholecalciferol corrects glucose intolerance in hemodialysis patients. Kidney Int 1992; 41: 1048-1054
9. Borissova AM, Djambazova A, Todorov K, Dakovska L, Tankova T, Kirilov G. Effect of erythropoietin on the metabolic state and peripheral insulin sensitivity in diabetic patients on hemodialysis. Nephrol Dial Transplant 1993; 8: 93-95
10. Chagnac A, Korzets A, Zevin D, Korzets A, Hirsh J, Gafter U, Levi J. Effect of erythropoietin on glucose tolerance in hemodialysis patients. Clin Nephrol 1994; 42: 398-400
11. Mak RH. Metabolic effects of erythropoietin in patients on peritoneal dialysis. Pediatr Nephrol 1998; 12: 660-665
12. Stefanovic V, Nesic V, Stojimirovic B. Treatment of insulin resistance in uremia. Int J Artif Organs 2003; 26: 100-104
13. NKF K/DOQI Clinical practice guidelines 2000 The National Kidney Foundation. www.kidney.org/professionals/doqi/guidelines
14. Shoji T, Emoto M, Nishizawa Y. HOMA index to assess insulin resistance in renal failure patients. Nephron 2001; 89: 348-349
15. Beck-Nielsen H. Insulin resistance: Organ manifestations and cellular mechanisms. Ugeskr Laeger 2002; 164: 2130-2135
16. Mak RH. Effect of recombinant human erythropoietin on insulin, amino acid, and lipid metabolism in uremia. J Pediatr 1996; 129: 97-104
17. Wu Z, Bao X. Effects of benazepril on insulin resistance and glucose tolerance in uremia. Clin Nephrol 1998; 50: 108-112
18. Eschback JW, Kelly MR, Haley NR, Abels I, Adamson JW. Correction of anemia in progressive renal failure with recombinant human erythropoietin. N Engl J Med 1989; 321: 158-163
19. Barrany P, Peterson E, Ahberg M, Hultman E, Bergstrom J. Nutritional assessment in anemic hemodialysis patients treated with human recombinant erythropoietin. Clin Nephrol 1991; 35: 270-279
20. Mak RH, Turner C, Haycock GB, Chantier C. Secondary hyperthyroidism and glucose intolerance in children with uremia. Kidney Int 1983; 16(Suppl 24): 122